Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
BACKGROUND
A 48-year-old man with a recent diagnosis of multiple myeloma and rapidly progressive oliguric end-stage renal disease requiring hemodialysis, presented with a serum calcium concentration of 3.4 mmol/l (13.6 mg/dl).


METHODS
Serum laboratory analysis, electroencephalogram, MRI of the brain and bone marrow, and kidney biopsies.


METHODS
Hypercalcemia secondary to multiple myeloma.


RESULTS
Short-term intravenous disodium pamidronate therapy (30 mg daily) and daily monitoring of serum calcium concentration.
Trimarchi
Hernán
H
Department of Medicine, Hospital Británico de Buenos Aires, Argentina. htrimarchi@hotmail.com
Lombi
Fernando
F
Forrester
Mariano
M
Elizondo
Cristina
C
Sawinski
Deirdre
D
Pereyra
Horacio
H
Freixas
Emilio
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D000077268:Pamidronate; D006435:Renal Dialysis
D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate